Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

USD 3,000

* Required Fields

USD 3,000


Be the first to review this product

Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in funding from the National Institutes of Health (NIH) and other government agencies. As a result, these investments have led to significant growth in new product and application development, thereby creating new market segments and revenue growth opportunities for existing companies and new entrants.

In 2017, the CRISPR/Cas9 tools market opportunity will likely be about $1.8 to $2 billion. The therapeutics and agriculture segments will contribute the most revenue potential. The market is currently highly fragmented, with a handful of global participants and a large number of application-focused participants operating in their respective segments. Competition in the therapeutics and agriculture domains is highly concentrated, and most market and technology developments have been focused around a few companies. Even large pharmaceutical companies have partnered with these existing participants to source innovation and to support their product development using CRISPR. With the ongoing patent war between the University of California and Broad Institute, this situation will likely remain the same. Frost & Sullivan expects that large pharmaceutical companies will only commit direct investments in this segment after understanding the final outcome of the ongoing patent cases.

The objective of this research study is to consider and analyze all these market developments and present a realistic market landscape. This research publication covers insights on existing and emerging growth opportunities in the CRISPR/Cas9 tools market. The study covers qualitative market insights on various market segments and sub-segments, including agriculture, human therapeutics, research tools, and drug discovery activities. The report identifies existing gaps in product and service offerings of key participants across segments, disruptive technologies, and key market and technology trends. The research study further delves into the market’s competitive landscape and patent licensing landscape analysis.

Key Questions This Study Will Answer:
•     Who are the key competitors in the emerging CRISPR/Cas9 market, both tools and therapeutics?
•     What are the growth opportunities that companies should pursue now and in the future?
•     To stay relevant, what are the competitive differentiators that companies should employ in an increasingly crowded competitive base?
•     What is the current patent landscape for this domain, and what are the key associated opportunities?
•     What are the key game-changing disruptive technologies that might impact future market development?

Table of Contents

1. Executive Summary
Key Findings
Market Definitions and Other Gene-editing Options
Scope and Segmentation—CRISPR/Cas9 Tools Market
Market Background and Overview
2. Growth Drivers and Opportunities
Key Market Drivers
Key Market Restraints
CRISPR/Cas9 Research Funding Growth
CRISPR/Cas9 Tools Market Potential
3. Growth Opportunities
Growth Opportunity 1—CRISPR Therapeutics Development
CRISPR Therapeutics—Collaboration and Partnerships
Competitive Ecosystem of the CRISPR Therapeutics Segment
Potential Opportunities
Growth Opportunity 2—Animal and Disease Model Development
Product Portfolio Benchmarking and Gap Analysis
Key Market Opportunities
Growth Opportunity 3—CRISPR Research and Design Tools
Product Portfolio Benchmarking and Gap Analysis
Key Market Opportunities
Growth Opportunity 4—Drug Compound and Target Screening
Growth Opportunity 5—Agriculture and Nutritional Healthcare Products
CRISPR in Agriculture—Current Status and Future Applications
4. Growth Opportunities Matrix
Growth Opportunity Matrix—Key Opportunities and Business Impact
5. Key Market Trends and Impact Analysis
Market Trends
Market Impact of Top Trends
6. Competitive Analysis
Competitive Environment
Key Market Companies
Companies to Action
Competitor List
7. Patient Licensing Landscape
Patent Licensing—Current Landscape
8. Potential Game-changing Disruptive Technologies
Potential Game-changing Disruptive Technologies
9. Strategic Imperatives
Strategic Imperatives for CRISPR/Cas9 Companies
Legal Disclaimer
10. The Frost & Sullivan Story

List of Figures & Charts

1. CRISPR/Cas9 Tools Market: Key Market Drivers, Global, 2018–2021
2. CRISPR/Cas9 Tools Market: Key Market Restraints, Global, 2018–2021
3. CRISPR/Cas9 Tools Market: Competitive Structure, Global, 2017
4. CRISPR/Cas9 Tools Market: Competitor List, Global, 2017

1. CRISPR/Cas9 Tools Market: NIH—Funding of Related Projects, US, 2012–2016
2. CRISPR/Cas9 Tools Market: Growth Opportunity Matrix, Global, 2018–2021
3. CRISPR/Cas9 Tools Market: Impact of Top Trends, Global, 2018–2021


Related Research

Release Date : 29-Dec-17

Region : North America

Release Date : 20-Dec-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.